Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CAPN1 | P07384 | 3/20 | 0.47 |
| ▸ | NTSR2 | O95665 | 10/20 | 0.44 |
| ▸ | NTSR1 | P30989 | 10/20 | 0.44 |
| ▸ | CALCRL | Q16602 | 1/20 | 0.44 |
| ▸ | REN | P00797 | 1/20 | 0.44 |
| ▸ | SORT1 | Q99523 | 9/20 | 0.43 |
| ▸ | XIAP | P98170 | 1/20 | 0.42 |
| ▸ | RAMP3 | O60896 | 3/20 | 0.42 |
| ▸ | CALCR | P30988 | 3/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31232524 | 0.92 | CAPN1 (0.46) | CAPN1NTSR2NTSR1CALCRLREN | |
| SCHEMBL30612511 | 0.91 | CAPN1 (0.54) | CAPN1NTSR2NTSR1CALCRLSORT1 | |
| SCHEMBL30690935 | 0.87 | KMT2A (0.48) | CAPN1NTSR2NTSR1SORT1XIAP | |
| SCHEMBL30401355 | 0.85 | CALCRL (0.52) | CAPN1NTSR2NTSR1CALCRLRAMP3 | |
| SCHEMBL29569025 | 0.84 | NTSR2 (0.52) | CAPN1NTSR2NTSR1RENSORT1 | |
| SCHEMBL31518645 | 0.84 | KMT2A (0.45) | CAPN1NTSR2NTSR1RENRAMP3 | |
| SCHEMBL30799598 | 0.84 | CAPN1 (0.51) | CAPN1NTSR2NTSR1CALCRLREN | |
| SCHEMBL30311400 | 0.84 | CALCRL (0.45) | CAPN1NTSR2NTSR1CALCRLXIAP | |
| SCHEMBL31140791 | 0.84 | CALCRL (0.46) | CALCRLRENRAMP3CALCR | |
| SCHEMBL31518678 | 0.84 | CAPN1 (0.45) | CAPN1RENXIAPKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022190064-A1 | METHODS FOR IDENTIFYING SUBJECTS WITH BETACORONAVIRUS INFECTIONS WHO ARE AT RISK OF ACUTE RESPIRATORY SYNDROME AND METHODS FOR THE TREATMENT OF SAME | VEXO PHARMACEUTICALS DMCC (AE) | 2022-09-15 | — | — | WO | disclosed |